Limits...
Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma.

Zhang J, Yin L, Wu J, Zhang Y, Xu T, Ma R, Cao H, Tang J - Exp Ther Med (2014)

Bottom Line: However, the levels were not associated with age or gender (P>0.05).In addition, the serum level of MMP-9 exhibited a significantly correlation with the VEGF level (r=0.601, P<0.001).Subgroup analysis revealed that in patients with IDC, serum levels of VEGF and MMP-9 prior to surgery were significantly higher than those following surgery (P<0.05).

View Article: PubMed Central - PubMed

Affiliation: Department of Oncology, Xuzhou Medical College, Xuzhou, Jiangsu 221004, P.R. China.

ABSTRACT
The aim of the present study was to assess the effect of the combined detection of serum vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) by Luminex multiplexed assays for the diagnosis, treatment and prognosis of breast cancer. Preoperative levels of serum VEGF and MMP-9 were detected via a lipid chip-based method in 301 breast cancer cases, 83 breast fibroadenoma cases and 40 healthy adults. Postoperative levels of VEGF and MMP-9 were also detected in 118 breast cancer cases. The levels of serum VEGF and MMP-9 in patients with breast infiltrative ductal carcinoma (IDC) were higher than those in the breast fibroadenoma and healthy control groups (P<0.05); there was no statistically significant difference between the breast fibroadenoma and healthy groups (P>0.05). The levels of VEGF and MMP-9 were shown to correlate with the clinical stage, tumor size and the lymph node metastasis status. However, the levels were not associated with age or gender (P>0.05). In addition, the serum level of MMP-9 exhibited a significantly correlation with the VEGF level (r=0.601, P<0.001). Subgroup analysis revealed that in patients with IDC, serum levels of VEGF and MMP-9 prior to surgery were significantly higher than those following surgery (P<0.05). Therefore, the serum levels of VEGF and MMP-9 can be used as markers for the diagnosis of breast IDC and may also be valuable for the prediction of lymph nodes metastasis.

No MeSH data available.


Related in: MedlinePlus

Area under the ROC curves for the levels of serum (A) VEGF and (B) MMP-9 in IDC patients and healthy individuals. ROC, receiver operating characteristic; VEGF, vascular endothelial growth factor; MMP-9, matrix metalloproteinase-9; IDC, infiltrative ductal carcinoma.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4061234&req=5

f4-etm-08-01-0175: Area under the ROC curves for the levels of serum (A) VEGF and (B) MMP-9 in IDC patients and healthy individuals. ROC, receiver operating characteristic; VEGF, vascular endothelial growth factor; MMP-9, matrix metalloproteinase-9; IDC, infiltrative ductal carcinoma.

Mentions: Receiver operating characteristic (ROC) curve analysis (Fig. 4) revealed the area under the ROC curve for VEGF was 0.788 (95% confidence interval, 0.711–0.864), whereas for MMP-9, the area under the ROC curve was 0.861 (95% confidence interval, 0.806–0.916). Thus, serum VEGF and MMP-9 levels may be used as markers for the diagnosis of breast IDC.


Detection of serum VEGF and MMP-9 levels by Luminex multiplexed assays in patients with breast infiltrative ductal carcinoma.

Zhang J, Yin L, Wu J, Zhang Y, Xu T, Ma R, Cao H, Tang J - Exp Ther Med (2014)

Area under the ROC curves for the levels of serum (A) VEGF and (B) MMP-9 in IDC patients and healthy individuals. ROC, receiver operating characteristic; VEGF, vascular endothelial growth factor; MMP-9, matrix metalloproteinase-9; IDC, infiltrative ductal carcinoma.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4061234&req=5

f4-etm-08-01-0175: Area under the ROC curves for the levels of serum (A) VEGF and (B) MMP-9 in IDC patients and healthy individuals. ROC, receiver operating characteristic; VEGF, vascular endothelial growth factor; MMP-9, matrix metalloproteinase-9; IDC, infiltrative ductal carcinoma.
Mentions: Receiver operating characteristic (ROC) curve analysis (Fig. 4) revealed the area under the ROC curve for VEGF was 0.788 (95% confidence interval, 0.711–0.864), whereas for MMP-9, the area under the ROC curve was 0.861 (95% confidence interval, 0.806–0.916). Thus, serum VEGF and MMP-9 levels may be used as markers for the diagnosis of breast IDC.

Bottom Line: However, the levels were not associated with age or gender (P>0.05).In addition, the serum level of MMP-9 exhibited a significantly correlation with the VEGF level (r=0.601, P<0.001).Subgroup analysis revealed that in patients with IDC, serum levels of VEGF and MMP-9 prior to surgery were significantly higher than those following surgery (P<0.05).

View Article: PubMed Central - PubMed

Affiliation: Department of Oncology, Xuzhou Medical College, Xuzhou, Jiangsu 221004, P.R. China.

ABSTRACT
The aim of the present study was to assess the effect of the combined detection of serum vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) by Luminex multiplexed assays for the diagnosis, treatment and prognosis of breast cancer. Preoperative levels of serum VEGF and MMP-9 were detected via a lipid chip-based method in 301 breast cancer cases, 83 breast fibroadenoma cases and 40 healthy adults. Postoperative levels of VEGF and MMP-9 were also detected in 118 breast cancer cases. The levels of serum VEGF and MMP-9 in patients with breast infiltrative ductal carcinoma (IDC) were higher than those in the breast fibroadenoma and healthy control groups (P<0.05); there was no statistically significant difference between the breast fibroadenoma and healthy groups (P>0.05). The levels of VEGF and MMP-9 were shown to correlate with the clinical stage, tumor size and the lymph node metastasis status. However, the levels were not associated with age or gender (P>0.05). In addition, the serum level of MMP-9 exhibited a significantly correlation with the VEGF level (r=0.601, P<0.001). Subgroup analysis revealed that in patients with IDC, serum levels of VEGF and MMP-9 prior to surgery were significantly higher than those following surgery (P<0.05). Therefore, the serum levels of VEGF and MMP-9 can be used as markers for the diagnosis of breast IDC and may also be valuable for the prediction of lymph nodes metastasis.

No MeSH data available.


Related in: MedlinePlus